chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: TD
Symptoms: Injection site reaction
Clinical narrative: Injection site reaction; Initial information was received on 27-May-2021 regarding an unsolicited valid non-serious case from a consumer/non-hcp (healthcare professional).  This case involves a 29 years old female patient who experienced injection site reaction while receiving vaccine DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC].  The patient's past medical treatments, past vaccinations, concomitant medication and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (Suspension for injection, lot number and expiration date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious injection site reaction (unknown latency) following the administration of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT.  Laboratory data was not reported.  It is unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.  There will be no information on the batch number for this case.
Age: 1.33
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation error
Clinical narrative: patient was administered a 0.5ml dose of the diluent of the Pentacel vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from the other healthcare professional via Medical Information inbound (reference number- 00608210) and transmitted to Sanofi on 19-May-2021.  This case involves 16 month old male patient who was administered a 0.5ml dose of only the diluent of the DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot number: U6842BA; expiry date: 05-JUL-2021) via unknown route in the right thigh for prophylactic vaccination on 17-MAY-2021(product preparation error).  Medical history, medical treatment(s), past vaccination(s), and family history were not provided.  Concomitant medications included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR VACCIN) for prophylactic vaccination on 17-MAY-2021.   It was a case of an actual medication error due to active ingredient not added to diluent (latency same day).  The reporter stated that a nurse administered the diluent only regarding the Pentacel. The reporter wanted to know what if a vaccination with just a stand alone vaccine for the components not given by just administering the diluent. Also, the reporter wanted to know if the powder component be given if diluted with something else.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.67
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: Ipol that had undergone temperature excursion on 16MAY2021, and was recommended that it not be used, had been given to patient with no adverse event; Initial information was received on 20-May-2021 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 20 months old female patient who was administered 0.5 ml third dose of suspect IPV (VERO) [IPOL] (lot R1D972M, expiry date: 17-JUL-2021) via intramuscular route in the left thigh for prophylactic vaccination on 19-May-2021 (Product storage error)  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP); HEPATITIS A VACCINE and PNEUMOCOCCAL VACCINE 13V for prophylactic vaccination.  It was a case of an actual medication error due to Incorrect product storage.  At the time of report, no adverse event was reported.  Caller stated that she called to get stability for IPOL because it was puncture and she was advised to discard. Caller stated before she could take it out of the fridge it was administered to a child. She would like to know what should be done from here. Ipol that had undergone temperature excursion on 16MAY2021, and was recommended not be used  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: patient erroneously received reconstituted HIB portion of the PENTACEL vaccine after diluting with sterile water/ NO AE; Initial information regarding an unsolicited valid non-serious case was received from a physician and other healthcare professional via Medical Information via call-center (Reference number- 00609908) and transmitted to Sanofi on 20-May-2021.  This case involves a 2-months-old male patient (unknown demographics) to whom nurse administered the first dose of 0.5 mL HIB portion DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (frequency: once, strength: standard, batch number: UJ415AA and expiry date not reported via intramuscular route at an left thigh administration site) after diluting with sterile water then administered the DTaP-IPV portion of PENTACEL in the right thigh (product preparation error) on 20-May-2021 for prophylactic vaccination.  The patient's medical history, past medical treatment, vaccination, and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and HEPATITIS B VACCINE for prophylactic vaccination.  It was an actual medication error case due to wrong solution used in drug reconstitution (latency: same day).  Nurse requests escalation for question: Did the patient receive any protection from the erroneously reconstituted HIB portion of the PENTACEL vaccine. She asks why it is not valid and requests information regarding why specific diluent; 0.4 percentage NaCl must be used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: An expired dose of Pentacel was given to a patient, no AE; Initial information regarding an unsolicited valid non-serious case was received from a other health care professional via Global Medical Information (GMI) (Reference number- 00611112) and transmitted to Sanofi on 21-May-2021.  This case involves a 6 months old male patient who was administered 0.5 ml second dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ259AAA, expiry date: 14-May-2021, powder vial- Lot: UJ259AA and liquid vial-lot: UJ331AA, expiry date: 14-May-2021) once via intramuscular route in the left vastus lateralis for prophylactic vaccination on 20-May-2021 (Expired product administered).  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE 13V, HEPATITIS B VACCINE and ROTAVIRUS VACCINE for prophylactic vaccination.  It was a case of an actual medication error due to Expired vaccine used (latency same day)  The reporter stated that yesterday (20-May-2021) an expired Pentacel was given to a patient and wanted to know what needs to be done now. The reporter asked whether another dose can be given to the patient. The Pentacel had expired 1 week ago. It was reported that they will call the patient's parents  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: 12 year old patient was administered an expired Menactra, no AE; Initial information regarding an unsolicited valid non-serious case was received from the other healthcare professional via Medical Information inbound (reference number-00613470) and transmitted to Sanofi on 24-May-2021.  This case involves a 12 year old female patient who was administered an expired 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number: U6576AB; expiry date: 04-APR-2021) via intramuscular route in the left arm for prophylactic vaccination on 24-MAY-2021 (expired product administered).  Medical history, medical treatment(s), past vaccination(s), and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (BOOSTRIX) for prophylactic vaccination.   It was a case of an actual medication error due to expired vaccine used (latency same day).  The reporter was asking for appropriate follow up.    At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine refrigerator experienced an unreported temperature excursion greater than 72 hours/no AE; stability data of product was not provided.
Age: 0.58
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: an expired Pentacel dose was given to a patient with no reported adverse event; Initial information regarding an unsolicited valid non-serious was received from a Physician via Medical Information (Reference number- 00616586) and transmitted to Sanofi on 26-May-2021.  This case involves a 7 months old male patient who received a 0.5 mL expired dose (second dose) of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] (lot UJ162ABA and expiry date: 24-Apr-2021) via intramuscular route in the right thigh (expired product administered) for prophylactic vaccination on 26-May-2021.  The patient's medical history, past medical treatments, past vaccinations, concomitant medication and family history were not provided.   The reporter wanted to know wanted to know if it should be counted as a valid dose or if patient needs revaccination.  It was an actual medication error case due to expired vaccine used (latency: same day).  At the time of reporting, the patient experienced no adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: DTAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received a Daptacel vaccine that was two days expired with no reported adverse event; Initial information was received on 26-May-2021 regarding an unsolicited valid non-serious case from a consumer in the .  This case involves an unknown demographic patient who received DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] that was two days expired (lot number- C5621AA and expiry date-23-MAY-2021] via an unknown in unknown administration site on 25-MAY-2021 for prophylactic vaccination (expired product administered).  Medical history, medical treatment, vaccination, concomitant medications and family history were not provided.  It was an actual medication error due to expired vaccine used. (latency: same day).  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 8.0
Sex: F
Vaccine: IPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: A patient received an expired vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional via Medical Information (Reference number- 00616843) and transmitted to Sanofi on 26-May-2021.  This case involves an eight-year-old female patient who received 0.5 mL dose of expired IPV (VERO) [IPOL] (lot R1B251M and expiry date: 13-Mar-2021) via an intramuscular route in the left deltoid for prophylactic vaccination on 26-May-2021 (expired product administered).  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for prophylactic vaccination.  The reporter was asking what the accuracy of expiration date was and the potential for immunity for this administration.  This was a case of actual medication error due to expired vaccine used (latency same day).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: TDAP, UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event; Stability data not provided in temperature excursion  hence non-case.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received an expired Pentacel, no adverse event; Initial information was received on 26-May-2021 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 4 month old female patient who received 0.5 ml first dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] (lot UJ29AAA, expiry date: 14-May-2021) via intramuscular route in left leg for prophylactic vaccination on 26-May-2021  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for prophylactic vaccination.  It was a case of an actual medication error due to Expired product administered (latency same day)  The reporter asked if the patient need to be revaccinated  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.17
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was kept at 9 degree Celsius for approx 30 minutes, no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional via Medical Information (Reference number- 00617255) and transmitted to Sanofi on 26-May-2021.  This case involves a two-month-old female patient who received 0.5 mL dose of IPV (VERO) [IPOL] (lot R1F801M and expiry date: not reported) via an intramuscular route in the left thigh for prophylactic vaccination on 15-Mar-2021 which was kept at 9 degree Celsius for approx. 30 minutes on 09-Mar-2021 (product storage error).  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS B VACCINE (HEPATITIS B VACCINE), DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL), MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) and DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (TENIVAC) for prophylactic vaccination.  A clinic calling to report that Ipol was given post a temperature excursion that made the vaccine not useable. The caller reported that the excursion occurred on 09-Mar-2021, that the excursion was spotted during an audit of temperatures from a data logger and three consumers received the vaccine. With further verifying dates and times of vaccine administration only two consumers received the vaccine.   This was a case of actual medication error due to incorrect product storage (latency unknown).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given an expired dose of Menactra with no adverse event; Initial information regarding an unsolicited valid non-serious was received from a Consumer/non-hcp (healthcare professional) via Medical Information (Reference number- 00618521) and transmitted to Sanofi on 27-May-2021.  This case involves a 17 years old female patient who received an 0.5 mL expired dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot U6596AA and expiry date: 24-May-2021) via unknown route in unknown administration site (expired product administered) for prophylactic vaccination on 27-May-2021.  The patient's medical history, past medical treatments, past vaccinations and family history were not provided.  Concomitant medications included POLIO VACCINE (POLIO VACCINE) and HEPATITIS B VACCINE (HEPATITIS B VACCINE) for Immunisation.  It was an actual medication error case due to expired vaccine used (latency: same day).  At the time of reporting, the patient experienced no adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 20.0
Sex: M
Vaccine: RAB
Symptoms: No adverse event, Product dose omission issue
Clinical narrative: The patient was unable to receive his Imovax vaccination today because it was not in stock with no adverse event; Initial information was received on 27-May-2021 regarding an unsolicited valid non-serious case from a pharmacist (Inquiry number: 00618801).  It was reported that 20 years old male patient was unable to receive his RABIES (HDC) VACCINE [IMOVAX RABIES] (Suspension For Injection) today because it was not in stock on an unknown date for prophylactic vaccination (Product dose omission issue).  It was a case of potential medication error due to missed dose.  Pharmacist states that a patient, the patient was supposed to receive an Imovax vaccination on 27May2021. His last vaccination was received on 20May2021. The patient was unable to receive his Imovax vaccination today because it was not in stock. The pharmacist states that the Imovax will be in stock tomorrow and the patient will be able to receive it then.  At the time of report, no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on batch number for this case.
Sex: F
Vaccine: RAB
Symptoms: No adverse event, Product dose omission issue, Syringe issue
Clinical narrative: Patient missed her dose with no AE; all the medicine came out from syringe with no AE; Initial information regarding an unsolicited valid non-serious was received from a Nurse via Medical Information (Reference number- 00619945) and transmitted to Sanofi on 28-May-2021.  This case involves a 22 years old female patient who missed her dose (product dose omission issue) of suspect IPV (VERO) [IMOVAX] (lot T2A47 and expiry date: 17-Jun-2022) as all the medicine came out from syringe (syringe issue) on an unknown date.  The patient's medical history, past medical treatments, past vaccinations, concomitant medication and family history were not provided.  It was reported that reporter picked up the vaccine from the pharmacy whom purchased it from their wholesaler. Nurse state that when reporter was preparing the Imovax. Reporter reconstitute the medicine and pulled the Imovax up using the syringe the vaccine came with and when reporter was drawing it up nothing stopped and it completely opened up the syringe came out and opened up at the bottom and all the medicine came out. Reporter states the syringe was loose at the bottom and completely slid open it was thought the rubber was too small for the syringe. Reporter states she was pulling medicine out of the vial.  It was also a case of actual medication error due to missed dose (latency: same day).  At the time of reporting, the patient experienced no adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: FLUC3
Symptoms: Eye pain, Eye pruritus, Vision blurred, Visual acuity tests abnormal
Clinical narrative: Piercing, itching of left eye when in supine position; Piercing, itching of left eye when in supine position; Left eye was cloudy; This spontaneous case was received on 29-May-2021 via Communication (reference number: SEQW21-01390) from other non-health professional and concerned female patient, of an unreported age.  The patient's concurrent conditions included seasonal allergies. The patient's concomitant medications included Zink (zinc gluconate), for an unreported indication.   On 19-Nov-2021, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number was not reported.  On the same day, after receiving Flucelvax Quadrivalent, the patient experienced piercing, itching of left eye when in supine position and her left eye was cloudy.  On an unknown date, vision test was performed and results were worse in left eye. The patient administered allergy eye drops and an eye doctor gave steroid eye drop to the patient.  On an unknown date, the patient recovered from the events.   The reporter did not provide causality assessment.  The reporter assessed the case as non-serious.  Company comment: A female patient, of an unreported age was administered Flucelvax Quadrivalent. On the same day, after receiving Flucelvax Quadrivalent, the patient experienced piercing, itching of left eye when in supine position and her left eye was cloudy. The patient's concurrent conditions included seasonal allergies. Causal role of the suspect vaccine is assessed as possibly related for all events, due to plausible chronology.; Sender's Comments: A female patient, of an unreported age was administered Flucelvax Quadrivalent. On the same day, after receiving Flucelvax Quadrivalent, the patient experienced piercing, itching of left eye when in supine position and her left eye was cloudy. The patient's concurrent conditions included seasonal allergies. Causal role of the suspect vaccine is assessed as possibly related for all events, due to plausible chronology.
Age: 50.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Dizziness, Feeling cold
Clinical narrative: Light headed and cold chills.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hyperventilation, Nausea, Paraesthesia
Clinical narrative: pt had appt for Covid-19 vaccine  1st dose.  Upon receiving vaccine, within 5-7 minutes patient was hyperventilation, complaining of Nausea, "tingling of Limbs", appeared flushed. 911 was called and she went home, refused  Emergency visit.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood urine present, C-reactive protein increased, Dizziness, Neutrophil percentage increased, Red blood cell sedimentation rate increased
Clinical narrative: Patient has a history of simple Prostatectomy and Kidney Stone. He had the first Moderna Covid 19 vaccine on 2/3/2021 and the second dose 3/8/2021. 5 days ago He started with severe dizziness and next day he was admitted to hospital for severe Urosepsis.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis abnormal, Urine leukocyte esterase positive, Urosepsis, White blood cell count increased, White blood cells urine positive
Clinical narrative: Patient has a history of simple Prostatectomy and Kidney Stone. He had the first Moderna Covid 19 vaccine on 2/3/2021 and the second dose 3/8/2021. 5 days ago He started with severe dizziness and next day he was admitted to hospital for severe Urosepsis.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: PATIENT WENT ON LEAVE FOR  OVER  3 MOS AFTER 1ST VACCINE, AND CAM E BACK FOR  2ND  VACCINE IN MAY HE HAD NO ADVERSE REACTION,    HE RECIEVED SHOT 2 ON MAY 12,2021 AND 3RD VACCINE  JUNE 2,2021..  HE WAS TOLD TO START SERIES OVER AND GET A THIRD VACCINE  AFTER  SECOND WEAS  DELAYED .
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Arthralgia, Blood albumin decreased, Blood culture negative, Blood fibrinogen increased
Clinical narrative: Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Complement factor normal, Culture throat negative, Culture urine negative, Fibrin D dimer increased
Clinical narrative: Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin, Joint swelling, Mycoplasma test negative, Peripheral swelling, Pyrexia
Clinical narrative: Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Respiratory viral panel, Sterile pyuria, Streptococcus test, Urticaria
Clinical narrative: Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Myocarditis, Nausea, Troponin increased
Clinical narrative: patient received 2nd dose of Pfizer vaccine on 6/5/21. On the evening of 6/7/21 patient developed chest pain. When she woke up at 0530 on 6/8/21 her chest pain was still there. At this time patient developed nausea and was brought to the emergency room. In the emergency room she was found to have a troponin of 1155. She was started on indomethacin and colchicine for myocarditis.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Chills, Contusion, Erythema
Clinical narrative: Chills and hot flashes, extreme weakness and joint pain, tingling right hand that led to throbbing, swollen, red fourth finger tip. Pain in fourth finger tip continued for days, swelling diminished and purple bruises appeared.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hot flush, Pain, Paraesthesia, Peripheral swelling
Clinical narrative: Chills and hot flashes, extreme weakness and joint pain, tingling right hand that led to throbbing, swollen, red fourth finger tip. Pain in fourth finger tip continued for days, swelling diminished and purple bruises appeared.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Migraine, Vocal cord dysfunction
Clinical narrative: chronic migraines began 2 days after.  persisted for couple months.  vocal cord dysfunction for 3 months and ongoing.  Bagan 1 week after second vacccine
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Cardiac monitoring normal, Dizziness, Hyperhidrosis, Sinus rhythm
Clinical narrative: 46 y/o male c/o dizziness following Janseen vaccine. Pt was diaphoretic. No PMHx, No allergies, No meds. Vitals: BP=104/65, HR = 78, RR = 22, Sp02 = 97%. BBG = 114. Pt placed on medic stretcher and monitored for 45 minutes. Pt fully recovered and cleared by medical provider to go home with family. Last vitals: BP= 122/75, HR= 65, RR= 20, Sp02 = 98% RA. Cardiac monitor revealed NSR. Pt denied any symptoms when released.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Medical gave Moderna vaccine to 16 year old patient by mistake
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase normal, Basophil count decreased, Basophil percentage
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal, Blood chloride increased
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol increased, Blood creatinine normal, Blood glucose normal, Blood potassium normal, Blood sodium normal
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, Blood triglycerides normal, Blood urea normal, Carbon dioxide decreased, Chest X-ray normal
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Computerised tomogram head normal, Dizziness, Electrocardiogram abnormal
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil count normal, Eosinophil percentage, Essential hypertension, Glomerular filtration rate normal, Haematocrit normal
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin normal, Headache, High density lipoprotein normal, Hypertension, Immature granulocyte count
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular hypertrophy, Limb discomfort, Low density lipoprotein increased, Lymphocyte count normal, Lymphocyte percentage
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin decreased, Mean cell volume normal, Mean platelet volume normal, Monocyte count normal
Clinical narrative: You saw APRN-CNP on Tuesday June 1, 2021. The following issues were addressed: Benign essential hypertension; Dizziness; Acute nonintractable headache, unspecified headache type; and Abnormal EKG. PR ELECTROCARDIOGRAM, Blood pressure 150/100  O@ sat 95 %     6/2/2021 Chief complaint narrative was entered by triage nurse, not by physician.   12:34 PM patient, a 50 year old female with a past medical history that includes--migraine--presents to the ER c/o a HA. Pt had a HA for 2 days. Pt states it feels different than her normal migraine. She was seen at her PCP and reported she had an abnormal EKG and was found to be hypertensive. She also had nausea. Today, she developed chest pressure in the middle of her chest that radiated to her L arm. No hx of CAD. No other complaints or modifying factors at this time. Review of Systems Constitutional: Negative for chills, fever and weight loss. Respiratory: Negative for cough, shortness of breath and wheezing.   Cardiovascular: Positive for chest pain. Gastrointestinal: Positive for nausea. Negative for diarrhea and vomiting. Neurological: Positive for headaches.  All other systems reviewed and are negative.   BP (!) 140/101  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 1.651 m (5' 5")  | Wt 98.9 kg (218 lb)  | LMP  (LMP Unknown)  | SpO2 100%  | BMI 36.28 kg/m²